COMPANY

PENDOPHARM DIVISION OF PHARMASCIENCE INC

PENDOPHARM DIVISION OF PHARMASCIENCE INC: marketing authorisation holder for Bacitracin, Octreotide, Teriparatide, as stated by public registers.

MARKETING AUTHORISATION HOLDER

Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).

BacitracinBACITIN (DIN 00584908), Marketed Regulator Health Canada
OctreotideOCPHYL (DIN 02413191), Cancelled Post Market Regulator Health Canada
OctreotideOCPHYL (DIN 02413205), Cancelled Post Market Regulator Health Canada
OctreotideOCPHYL (DIN 02413213), Cancelled Post Market Regulator Health Canada
TeriparatideYORVIPATH (DIN 02565153), Approved Regulator Health Canada
TeriparatideYORVIPATH (DIN 02565161), Marketed Regulator Health Canada
TeriparatideYORVIPATH (DIN 02565188), Marketed Regulator Health Canada

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.